Erste Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Erste Asset Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-37,000	Closed	-$1.96M	–	668
2026 Q1	$1.96M	Hold	37,000	–	–	0.02%	366
2025 Q4	$1.54M	Buy	+37,000	New	+$855K	0.01%	378

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Erste Asset Management's TERN Position: Q2 2026 in Review

Erste Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 37,000 shares — an estimated $1.96M sold.

Erste Asset Management first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $1.96M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Erste Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Erste Asset Management sold 37,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $1.96M.
Erste Asset Management first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Erste Asset Management's Terns Pharmaceuticals position peaked at $1.96M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.